PDMS Paper Hybrid Microfluidic Device for Rapid Pathogen Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diagnostic methods for bacterial meningitis are costly, time-consuming, and often ineffective in resource-poor settings, requiring specialized equipment and trained personnel, and fail to provide immediate and accurate multiplexed detection of pathogens like Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae.

Innovation Solution

Development of low-cost, paper-based microfluidic biochips that integrate loop-mediated isothermal amplification (LAMP) for rapid and sensitive pathogen detection, using a PDMS/paper hybrid system with pre-loaded primers and a portable heating system, allowing for simultaneous detection of multiple pathogens without the need for DNA extraction or specialized equipment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional diagnostic methods are used for bacterial meningitis, then detection accuracy can be maintained, but cost and time consumption increase significantly

Engineering Contradiction:
Improvepathogen detection accuracyVSAvoiddiagnosis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent combines multiple diagnostic functions (DNA extraction, LAMP amplification, and detection) into a single integrated microfluidic chip. This merging of functions allows simultaneous processing of multiple steps that were previously performed separately, achieving both rapid results (45 minutes) and high sensitivity detection without requiring separate equipment for each step.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The microfluidic chip is designed as a universal platform that can detect multiple pathogens (N. meningitidis, S. pneumoniae, H. influenzae) simultaneously using the same device architecture. The chip includes multiple reaction chambers that can perform different LAMP reactions in parallel, providing multiplexed detection capability without requiring separate diagnostic tools for each pathogen.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If conventional diagnostic equipment is used, then detection sensitivity can be ensured, but device complexity and cost increase

Engineering Contradiction:
Improvepathogen detection sensitivityVSAvoidequipment complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent employs a disposable microfluidic chip that integrates all necessary diagnostic components in a single-use device. This eliminates the need for expensive, complex, and reusable equipment like thermal cyclers and centrifuges. The chip is designed to be discarded after one use, reducing contamination risks and eliminating the need for expensive maintenance and calibration of complex equipment.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent replaces complex mechanical systems (thermal cyclers for PCR, centrifuges for separation) with a simplified isothermal amplification system. The LAMP reaction occurs at a constant temperature (65°C) maintained by a simple heating block, eliminating the need for complex temperature cycling mechanisms. Detection is achieved through visual observation of turbidity or color change, replacing the need for expensive real-time PCR instruments.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Measurement precision

If specialized equipment is used for pathogen detection, then detection accuracy improves, but ease of operation deteriorates

Engineering Contradiction:
Improvepathogen detection accuracyVSAvoidoperational simplicity
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The microfluidic chip is designed to perform sample processing automatically without requiring skilled operators. The chip's microfluidic channels and chambers are pre-configured to guide sample flow, perform lysis, and conduct LAMP reactions automatically. Users simply need to load the sample and incubate the chip at 65°C for 45 minutes, with results visible through simple visual observation or basic UV light inspection, eliminating the need for specialized training.

Inventive Principle:
Principle #25Self-service

4Measurement precision

If DNA extraction is performed separately before amplification, then detection accuracy improves, but processing time increases

Engineering Contradiction:
Improvedetection accuracyVSAvoidprocessing time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent merges the DNA extraction and amplification steps into a single integrated process within the microfluidic chip. The chip includes a lysis chamber where bacterial cells are lysed and DNA is released, which then flows directly into the LAMP amplification chamber. This eliminates the need for separate DNA extraction procedures and intermediate transfer steps, reducing total processing time to 45 minutes while maintaining detection accuracy through the isothermal LAMP amplification method.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The PDMS/paper hybrid microfluidic devices enable rapid, sensitive, and cost-effective detection of bacterial pathogens, achieving a limit of detection as low as 3 copies per LAMP zone within 45 minutes, suitable for point-of-care diagnostics in resource-limited settings, with stable performance over extended periods.

Implementation Method 1

Paper-based microfluidic devices have emerged as a promising platform for point-of-care diagnostics due to their low cost, portability, and ability to perform complex assays without external power sources

Methodology Applied
Scientific EffectCapillary action: Capillary Action

Implementation Method 2

integrate loop-mediated isothermal amplification (LAMP) for rapid and sensitive pathogen detection

Methodology Applied
Scientific EffectEnzymatic amplification: Enzyme

Implementation Method 3

using a PDMS/paper hybrid system with pre-loaded primers and a portable heating system

Methodology Applied
Scientific EffectThermal conduction: Conduction (thermal)

Data Source

PatentUS10875024B2Methods and compositions for paper-based and hybrid microfluidic devices integrated with nucleic acid amplification for disease diagnosis
Publication Date: 2020.12.29 BOARD OF RGT THE UNIV OF TEXAS SYST
  • US10875024B2 patent drawing
  • US10875024B2 patent drawing
  • US10875024B2 patent drawing

AI summary

Certain embodiments are directed to paper and its hybrid microfluidic devices integrated with nucleic acid amplification for simple, cost-effective, rapid, and sensitive pathogen detection, especially in low-resource settings.